Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > Thomson Reuters Report

<< Previous

Bullboard Posts

Next >>

Post by onions7777on Apr 24, 2018 4:57pm

273 Views

Post# 27934477

Thomson Reuters Report

Barewood is right. I posted a link here to the latest report. If you dont receive these daily its a good read. It shows you peer analysis, projected SP, and other various indicators.

Im personally on the fence right now with this, and I have no intention of trying to encourage anyone to sell in hopes of getting shares cheaper. I think it will drop some more, but thats just my opinion. Heres the most updated info, read and decide for yourself.

https://marketsandresearch.td.com/tdwca/Reports/Report?documentKey=1581-ABA02-1JPUI460UMKGETVHP2A7762B39

<< Previous

Bullboard Posts

Next >>

Twelve Labs partners with AWS to revolutionize video search with AI